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Abstract
Research into the cognitive enhancing effects of polyphenols is small but growing. Single doses of the stilbene polyphenol
resveratrol can increase cerebral blood flow (CBF) but have failed to improve cognitive performance in young, healthy cohorts.
As both CBF and overall energy expenditure are closely related to neural activity, this randomised, double-blind, placebo-
controlled, crossover investigation, assessed the metabolic consequences of resveratrol during high cognitive demand via indirect
calorimetry (ICa). Twenty-seven, self-reported healthy participants (15 male, 12 female; mean age = 22) who reported them-
selves free of any food intolerances and any herbal supplementation or prescription medications were recruited for the current
study. Participants arrived at the testing facility at 8 a.m. on three separate occasions to complete a serial subtraction demand
battery 45min and 2 and 3 h following administration with 500 mg, 250 mg trans-resveratrol or inert placebo, while connected to
an online gas analysis system. A series of within-subjects ANOVAs (with planned comparisons) revealed a significant shift
towards higher carbohydrate oxidisation during cognitive demand, as indexed by a significant increase in respiratory exchange
ratio (RER) at 45-min and 3-h time points, following administration of 500 mg resveratrol. Despite this, no subsequent
resveratrol-related benefits to cognitive performance were observed. These results show that acute supplementation with resver-
atrol in young, healthy adults can modulate fuel utilization during cognitive demand, yet this does not translate into clear
improvements in cognitive performance. This study adds further understanding behind the lack of cognitive effects of resveratrol
in young and or healthy individuals. Future research should direct efforts towards assessing the cognitive impact of resveratrol,
and other vasoactive polyphenols, in populations with age-related or dietary-induced metabolic deficits.
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Introduction
The brain is the most metabolic organ in the human body,
consuming disproportionately large energy resources despite
its relatively small size (Raichle 2010). As the brain cannot
store its own energy source, it is solely reliant on the delivery
of metabolic substrates (glucose/oxygen) via dilation of the
cerebral vasculature; this is then increased, upon demand, in
response to neural activity (Girouard and Iadecola 2006). The
release of nitric oxide (NO) is fundamental to this
neurovascular coupling (Dormanns et al. 2016), thus articles
that can amplify this response are hypothesised to improve the
provision of blood-borne neural fuel substrates. In addition,
interventions that endeavour to sustain or replenish adenosine
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triphosphate levels may also engender cognitive enhancing
effects (Owen and Sunram-Lea 2011).
The s t i lbene polyphenol resvera t ro l (3 , 4 ′ , 5
trihydroxystilbene) is a phytoalexin that has been found to
bolster NO synthesis within human endothelial cells in vitro
(Elíes et al. 2011). This has led to a growing body of research
observing acute resveratrol-mediated improvements to periph-
eral blood flow (Wong et al. 2011; Wong et al. 2012) and, in
turn, cerebrovascular functioning (Wong et al. 2016).
However, despite evidence of increased cerebral blood flow
(CBF) during cognitive task performance, no robust cognitive
benefits have been observed from acute or chronic resveratrol
administration in young, healthy adults (Kennedy et al. 2010;
Wightman et al. 2014; Wightman et al. 2015). This may po-
tentially suggest that the young, healthy participants may not
be able to utilise the increased supply of neural fuel substrates.
Interestingly, however, increased levels of oxygen extraction
have also been observed during task performance from acute
doses of resveratrol, as indexed by increased concentrations of
deoxygenated haemoglobin (Kennedy et al. 2010; Wightman
et al. 2014). Consequently, resveratrol may also influence sub-
strate oxidation and cerebral metabolic rate during cognitive
performance. It is important to note, however, that despite
reflecting the overall pattern of cerebral metabolic activity,
measuring the cerebral haemodynamic response neither quan-
tify the extent of cerebral metabolic change nor the relative
change of energy expenditure during cognitive performance
(Al Naher et al. 2016).
Indirect calorimetry (ICa) has been employed previously to
assess changes in metabolic rate during cognitive task perfor-
mance and has demonstrated sufficient sensitivity to detect
subtle changes in energy expenditure from differing intensities
of cognitive tasks; beyond that of somatic movements (Al
Naher et al. 2016). Although the use of ICa to measure the
metabolic consequences of nutritional supplements during
cognitive demand remains relatively novel, enhanced fat oxi-
dation and total energy expenditure have been observed dur-
ing cognitive task performance from acute multivitamin ad-
ministration (Kennedy et al. 2016). This is particularly inter-
esting given that the administration of individual vitamins
such as vitamins C and E have shown to improve endothelial
functioning (Ashor et al. 2015). By examining the metabolic
consequences of resveratrol during increased neural demand,
further support could be obtained for the capacity of resvera-
trol to modulate the hypothesised additional neural substrates
that are concomitant with relative increases in CBF. This is
supported by the notion that a good transport and utilisation of
the pulmonary gases measured for ICa (oxygen/carbon diox-
ide) also emphasise the efficiency of the cardiovascular re-
sponse to cognitive demand. Given the above, the current
study investigates the metabolic consequences and cognitive
effects of single acute doses of resveratrol during high cogni-
tive demand.
Materials and Methods
Participants
Twenty-seven (15 male, 12 female) participants reported
themselves to be in good health and to have good or corrected
vision. The average age of the sample was 22 years (SD 3.64),
with a mean stature of 1.74 m (SD 0.10) and mass of 69.30 kg
(SD 14.03). All participants also reported themselves to be
free of food intolerances and sensitivities, or any gastrointes-
tinal, hepatic or renal diagnoses. This was to ensure that no
extraneous factors would interfere with the absorption of the
treatments. Moreover, participants were excluded if they had
suffered any neurological trauma (such as a head injury) or
possess any neuropathologies. While individuals who report-
ed themselves to be taking any herbal supplements or pre-
scription medications (with the exception of the contraceptive
pill and topical acne medication) or consumed high amounts
of caffeine (≥ 6 cups of coffee/tea or its caffeine equivalent
daily) were also excluded from the current study. Finally, due
to the requirements of the tasks, participants were also exclud-
ed if they had a diagnosis of dyscalculia (or any relevant
learning difficulty). All participants were required to fast for
12 h (with the exception of water) and to avoid strenuous
exercise prior to each testing session. They received £60 for
their participation upon completion of the study. This study
received ethical approval from the Psychology Department
(within the Faculty of Health and Life Sciences) Ethics
Committee and was conducted according to the Declaration
of Helsinki (1964).
Cognitive Task Battery
The current task battery comprises three serial subtraction
tasks (serial 3, 7 and 17). For each task, participants were
presented with the standardised instruction screen, which in-
formed the participant to continuously subtract the serial num-
ber (either 3, 7 or 17) from a given starting number (between
800 and 999), as quickly and accurately as possible, using the
numeric keyboard in front of them to enter each response.
Upon giving their first answer, the starting number was then
removed from the screen and their response was to be men-
tally retained. Sequential responses were then entered but
were covered by an asterisk. Pressing the enter key signalled
the end of each response and cleared the three asterisks from
the screen. Each task lasted 5 min, thus each repetition lasted
for 15 min in total. With regard to incorrect responses, any
subsequent responses were recorded as correct if they were
accurate in relation to the new number. The task was scored
for the number of correct entries and the number of errors,
with the addition of these two outputs creating a ‘total’ num-
ber of attempts entered.
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To avoid any task-time bias, the order of the tasks was
counterbalanced in a Latin square. All tasks in each repetition
of the battery were completed in a continuous fashion, in order
to induce maximal cognitive demand and fatigue to the par-
ticipants. The rationale for the use of these tasks was based
upon previous research demonstrating their ability to increase
both fuel utilization and heart rate beyond that of peripheral
mechanisms (Scholey et al. 2001; Kennedy and Scholey
2000).
Other Measures
Two 100-mm visual analogue scales (VAS) were employed
prior to and following each repetition (completion of all three
serial subtraction tasks), measuring ‘Mental Tiredness’ and
‘Difficulty’ to assess any potential mood changes following
resveratrol consumption. Scales were anchored at either end
by ‘not at all’ and ‘extremely’; these were scored as a percent-
age along the line towards ‘extremely’.
Treatments
Active treatments of resveratrol were acquired from
megaresveratrol.net (Danbury, CT, USA). The integrity of
the extract used was 99.73%, as verified by the manufactures
statement. Treatments were administered on separate days,
with each testing session being conducted no more than 48 h
before, and no more than 14 days after the previous session.
During the three study visits, participants received three
single-dose treatments in an order dictated by random alloca-
tion to a (Latin Square) counterbalanced order. Two capsules
were consumed on each testing day either:
1) Two placebo capsules (CABOT MP5 fumed silica).
2) One 250-mg dose of resveratrol with one placebo.
3) Two 250 mg resveratrol capsules (equating to a 500-mg
dose).
All treatments were administered within the same size 0
vegetarian soft-gel capsules. All treatments were
counterbalanced and were prepared by the lead investigator.
The treatments were then coded by a third party who had no
further involvement in any aspect of the study. No member of
the investigational team was aware of the contents of the cap-
sules until completion of the statistical analysis.
Indirect Calorimetry
For the current investigation, oxygen uptake and carbon diox-
ide excretion were measured from expired pulmonary air
using an online analysis system (Metalyzer 3B, Cortex,
Leipzig, Germany). The standard formula was then employed
to calculate total energy expenditure carbohydrate and fat
oxidisation (Frayn 1983). The online gas analysis system
was attached to the participants via a facemask, which covered
both the nose and mouth, connected by Falconia tubing.
Procedure
Participants attended a visit to the Brain, Performance and
Nutrition Research Centre at Northumbria University on four
separate occasions. The first of the visits was to screen the
participant against the exclusion criteria and familiarise them
with the cognitive demand battery. The three subsequent visits
were testing visits and were identical to each other. All partic-
ipants arrived at 8 a.m., fully fasted (consuming nothing but
water) for 12 h having had also refrained from engaging in any
strenuous exercise prior to the session. Upon confirming con-
tinuous compliance with the inclusion criteria, participants
completed a brief rest before being connected to the gas anal-
ysis equipment via a facemask and mouthpiece. This was
adjusted to ensure there were no gaps and was fitted to the
participant’s comfort. After, participants completed a baseline
measurement of the serial subtraction task demand battery and
mood scales. Upon completion, participants were then discon-
nected from the gas analysis equipment and then administrat-
ed with their treatment for the day before continuing to rest for
45 min to allow for absorption. Thirty-five minutes into the
absorption period, participants were reconnected to the gas
analysis device before continuing to rest for the remaining of
the absorption period. Upon completion of the absorption pe-
riod, participants then completed the first of the post-dose
mood scales and cognitive demand battery. The participants
were then required to complete the battery and VAS scales at a
further 2 and 3 h post-administration time points. ICa mea-
sures were obtained throughout all task performances.
Participants were fully debriefed upon completion of the final
study visit. The timeline for a typical study day can be seen in
Fig. 1.
Analysis
All ICa analysis was completed within Minitab 17 Statistical
Software (State College, PA, Minitab, Inc.), while all behav-
ioural data was analysed in SPSS version 22 for Windows
(IBM SPSS Statistics Armonk, NY).
Treatment of Indirect Calorimetry Data
Raw data was extracted and averaged across 1-min epochs for
each task within the three individual post-dose repetitions.
Each of these five 1-min epochs was first cleaned before being
condensed and averaged to represent a 5-min average time
point. This cleaning process led to the removal of two full data
sets. A further data set was not included due to data catchment
J Cogn Enhanc
errors (missing baseline performance). The final sample for
ICa analysis was N = 24.
Main Indirect Calorimetry Analysis
All ICa data was converted to a change from baseline mea-
sure, in which the averages from the corresponding baseline
task performance were utilised. The collapsed 5-min individ-
ual epochs for each serial subtraction task were cleaned before
the initial analysis. All remaining ICa data during cognitive
task performance was converted to change from baseline,
utilising the relative baseline task performance from each task.
Analysis consisted of 3 × 3 × 3 within-subjects’ ANOVAs
assessing treatment (250 mg resveratrol, 500 mg resveratrol
and placebo) × task (serial 3, serial 7 and serial 17 subtrac-
tions) × repetition (× 3). Subsequently, planned comparisons
were conducted upon the emergence of significant interaction
effects, utilising the mean square (MS) error values from the
initial ANOVA. Only comparisons to placebo and not be-
tween active treatments were conducted.
Behavioural Analysis
Raw cognitive data was cleaned before being converted into a
change from baseline measure. One participant’s data was
removed due to failing to maintain at least 50% accuracy
across all three tasks across a testing session. Raw baseline
scores for each task were then analysed to assess if there was
any difference between treatment baseline scores. Following
this, nine within-subjects’ ANOVAs analysing treatment
(500 mg resveratrol, 250 mg resveratrol and placebo) × repe-
tition (× 3) × task (3 s, 7 s and 17 s) were conducted.
Prior to the mood analysis, scores for ‘concentration’ and
‘mental fatigue’ were converted to change from baseline; the
score submitted following completion of the baseline battery
of cognitive tasks was used as a baseline. Due to data catch-
ment errors (missing baseline performance) one participant’s
data was removed from the subsequent analysis. This resulted
in N = 26 data sets for the final analysis. Two within-subjects
ANOVAs investigating treatment (500mg resveratrol, 250mg
resveratrol and placebo) × repetition (× 3) × time (pre-com-
pletion and post-completion of the cognitive battery) were
conducted. This was followed up with Bonferroni corrected
post hoc pairwise comparisons on the presentation of a signif-
icant F test.
Results
Indirect Calorimetry Results
A series of repeated measures ANOVAs revealed no signifi-
cant main effect of treatment or treatment-related interactions
on total energy expenditure, carbohydrate and fat oxidisation
(all p > .05) during cognitive performance.
However, a within-subjects’ ANOVA demonstrated a sig-
nificant treatment × task × repetition interaction [F (8, 184) =
1.13, p = .039] on respiratory exchange ratio (RER), indicat-
ing a significant treatment-related change in fuel utilisation
during task performance. Follow-up planned comparisons
demonstrated that administration of 250 mg resveratrol
evinced a significant increase in RER at repetition 1 during
the serial 3 subtractions, p = .002 (95% CI = − .012, .035;
d = .29). Moreover, administration with 250 mg resveratrol
also significantly increased RER during serial 3 (p = .001;
95% CI = − .016, .042; d = .26) and 7 (p = .001; 95% CI =
− .018, .042; d = .24) task performance on the third repetition
in comparison to placebo. However, the same dose was found
to induce a significant reduction in RER during serial 17 task
performance (p < .001; 95% CI = − .019, .046; d = .24) on the
final repetition of the task battery in contrast to placebo. As
can be seen in Fig. 2, administration of 500 mg resveratrol
evinced an increase in RER across all tasks and repetitions in
comparison to placebo. These were found to be significant for
serial 3 (p = .029; 95% CI = − .016, .032; d = .20) and serial 7
(p = .018; 95% CI = − .016, .033; d = .21) subtraction
Fig. 1 Timeline for study 1 testing day
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performance at repetition 1 and for the same tasks during
repetition 3 (S3: p = .003; 95% CI = − .018, .040; d = .22)
(S7: p = .001; 95% CI = − .021, .046; d = .22).
Behavioural Results
A series of within-subjects ANOVAs revealed no significant
main treatment or treatment-related interactions on any sub-
measures of the cognitive or mood parameters in the current
study (all p > .05).
Discussion
Previous investigations have demonstrated that single, acute
oral doses of the resveratrol can modulate CBF. However,
such findings have failed to be complemented with clear im-
provements to cognitive performance. It is unclear whether
short-term increases in CBF can be beneficial to cognitive
performance in young, healthy cohorts. The current study
therefore aimed to assess the metabolic consequences and
cognitive effects of two single acute doses of resveratrol.
The results here showed that administration of both doses of
resveratrol induced significant increases in RER, although,
only the 500 mg dose of resveratrol demonstrated consistently
higher RER across all tasks and repetitions in comparison to
placebo; these were significant at the 45-min and 3-h time
points for the serial 3 and 7 subtraction tasks. No
resveratrol-mediated modulation of total energy expenditure
or cognitive performance was observed.
RER provides an insight to the body’s predominant fuel
source, with a higher RER indicative of carbohydrate being
the predominant fuel source, while a lower RER indicates fat
to be the principal fuel in use (Simonson and DeFronzo 1990).
As the tasks used in the current study have proven sensitive to
increased glucose utilisation (Scholey et al. 2001; Kennedy
and Scholey 2000) it is interesting to consider that resveratrol
can shift fuel oxidisation towards a higher utilisation of car-
bohydrate during high cognitive demand. It is noteworthy that
there is no consensus within the literature as to what a ‘typical’
RER response to cognitive demand entails. Only two investi-
gations at the time of writing have reported modulation of
RER during cognitive performance, with one reporting a sig-
nificant increase (Delistraty et al. 1991) and the other a signif-
icant decrease (Troubat et al. 2009) in RER across cognitive
demand. The direction of results here, demonstrate that RER
gradually decreased across the 3 post-treatment task intervals
(45 min, 2 h and 3 h) from an initially elevated RER. This
would suggest that the body switches from an initial high
carbohydrate source to a more oxidative supply (i.e. increased
fat oxidation) (Troubat et al. 2009); yet, after an acute dose of
500mg of resveratrol, carbohydrate oxidation remains slightly
elevated. In a recent review, Grassmann et al. (2016) note that
the excretion of carbon dioxide is sensitive to increasing cog-
nitive task difficulty. As a higher RER is characterised by an
increased ratio of carbon dioxide excretion to oxygen
Fig. 2 The acute effects of
250mg and 500mg resveratrol on
respiratory exchange ratio (RER).
Graph depicts mean changes in
change from baseline RER (with
SEM error bars), for the three
serial subtraction tasks during the
three repetitions of the post-dose
tasks in 24 healthy adults follow-
ing 500 mg resveratrol, 250 mg
resveratrol or placebo. *p < .05,
**p < .01 (in comparison to
placebo)
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inhalation, this may suggest that the elevated excretion of
carbon dioxide observed during the 500 mg resveratrol con-
dition may provide a proxy for increased exertion during cog-
nitive demand. However, in the absence of improved cogni-
tive functioning, it is unclear whether this increase in RER has
been beneficial.
The observation that resveratrol was unable to increase
total energy expenditure during cognitive demand is some-
what unanticipated. In addition to increased cerebral perfu-
sion, resveratrol is capable of activating 5′ adenosine
monophosphate–activated protein kinase (AMPK); a key reg-
ulator in energy-sensing procedures of the glycaemic re-
sponse, whole body metabolism and energy homeostasis
(Hardie et al. 2012). Thus, the ability of resveratrol to modu-
late such metabolic molecular targets may have beneficial
consequences for dietary and age-related metabolic complica-
tions (Kulkarni and Cantó 2015). Indeed, although most data
remains in vitro or from animal models, resveratrol (150 mg/
day) has been found to improve mitochondrial function in the
skeletal muscle after 30 days administration in obese, but oth-
erwise healthy men (Timmers et al. 2011). While a 3-day
supplementation of a combination of both resveratrol
(150 mg) and epigallocatechin-3-gallate (EGCG) (300 mg)
can increase both fasting and postprandial energy expenditure
at rest in obese humans (Most et al. 2016).
The lack of modulation of energy expenditure by resvera-
trol could equally suggest that the young, healthy sample
employed in this current study, as in other investigations, are
unlikely to be able to benefit metabolically from resveratrol
administration. Although CBF was not measured here, it is
noteworthy that the CBF response to sustained neural activity
is always greater than that of the rise in both the cerebral
metabolic rate of oxygen and ATP consumption (Leithner
and Royl 2014; Raichle and Gusnard 2002). As a result, any
further modulation of CBFmay lead to such subtle changes in
cerebral metabolism that they are unable to be detected in
healthy, young individuals. However, despite the lack of
resveratrol-mediated modulation of energy expenditure in
the current study, the ability to increase RER certainly sug-
gests that resveratrol can induce subtle, yet significant, meta-
bolic consequences during cognitive performance, which may
be of increased utility for those with either reductions in CBF
and or metabolic complications.
The lack of cognitive improvements observed in the
current study coincides with those of similar previous
investigations (Kennedy et al. 2010; Wightman et al.
2014; Wightman et al. 2015) and confirms that the
young, healthy sample employed here are likely unable
to benefit from resveratrol administration. Thus, research
into whether resveratrol can improve cognitive function-
ing in populations that possess cognitive deficits and or
a compromised supply of neural fuel substrates, such as
natural ageing populations, is warranted. Promising
resveratrol-mediated modulation of cerebral perfusion
has already been observed in individuals with type 2
diabetes mellitus (Wong et al. 2016) and post-
menopausal women (Evans et al. 2017), yet definitive
cognitive improvements in conjunction to these findings
are still lacking. In addition, more promise has been
seen with other vasodilating polyphenols when con-
sumed over longer periods of time. For example, im-
provements to cognitive functioning in healthy older
adults have been seen from 8 weeks administration of
520 mg and 993 mg of cocoa flavanols (Mastroiacovo
et al. 2015) and are likely predicated on NO-mediated
vasodilation (Fisher et al. 2003) and augmented cerebral
perfusion (Francis et al. 2006; Sorond et al. 2008;
Lamport et al. 2015). This more well-trodden path with
cocoa polyphenols gives promise that, via the same
vasodilatory mechanism, resveratrol may also improve
cognitive function by ameliorating a reduced blood flow
capacity, commonly associated with ageing.
Conclusion
The current study has added to the growing number of inves-
tigations into the potential cognitive enhancing properties of
the polyphenol resveratrol. Acute resveratrol administration
was unable to modulate energy expenditure or cognitive per-
formance. However, a 500-mg dose of resveratrol was capable
of increasing RER up to 3 h post-administration during cog-
nitive demand. This may suggest that resveratrol can shift fuel
oxidation, potentially as a method of supporting mental exer-
tion. Whether this provides a boon to cognitive functioning in
young, healthy cohorts is unclear. It is proposed that resvera-
trol administration will be more fruitful in populations that
suffer a mild reduction in neural fuel substrates or cognitive
deficits, such as those associated with natural ageing.
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